已收盤 05-10 16:00:00 美东时间
0.000
0.00%
HC Wainwright & Co. analyst Joseph Pantginis downgrades IMV (NASDAQ:IMV) from Buy to Neutral.
2023-05-02 18:16
IMV Inc. (the "Company" or "IMV") (NASDAQ:IMV, TSX:IMV), a clinical-stage biopharmaceutical Company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and
2023-05-02 00:32
隔夜跌近9%!奈飞广告业务开局不利;英伟达、AMD期权交易持续活跃,AMD获大摩分析师力捧;精密肿瘤学公司GH周四盘后一度重挫45%,隐波率维持高位 >>
2022-12-16 19:58
On Tuesday, 186 companies set new 52-week lows.
2022-07-12 23:36
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
2022-06-22 16:49
IMV (NASDAQ:IMV) reported its Q1 earnings results on Friday, May 13, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IMV reported in-line EPS of $-0.13 versus an estimate of $-0.13.
2022-05-13 19:53
IMV (NASDAQ:IMV) reported quarterly losses of $(0.13) per share. This is a 30 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $24.00 thousand in sales this quarter.
2022-05-13 19:20
智通财经APP获悉,12月28日(周一)美股盘前,截至北京时间21:04,生物制药公司IMV(IMV.US)涨10.94%,报3.380美元。该公司宣布,完成其...
2020-12-28 21:07